Literature DB >> 17593930

Comparative pharmacological profiles of morphine and oxycodone under a neuropathic pain-like state in mice: evidence for less sensitivity to morphine.

Minoru Narita1, Atsushi Nakamura, Masahiko Ozaki, Satoshi Imai, Kan Miyoshi, Masami Suzuki, Tsutomu Suzuki.   

Abstract

The present study was undertaken to investigate pharmacological actions induced by morphine and oxycodone under a neuropathic pain-like state. In the mu-opioid receptor (MOR) binding study and G-protein activation, we confirmed that both morphine and oxycodone showed MOR agonistic activities. Mice with sciatic nerve ligation exhibited the marked neuropathic pain-like behavior. Under these conditions, antinociception induced by subcutaneously (s.c.) injected morphine was significantly decreased by sciatic nerve ligation, whereas s.c. injection of oxycodone produced a profound antinociception in sciatic nerve-ligated mice. There were no significant differences in spinal or supraspinal antinociception of morphine and oxycodone between sham operation and nerve ligation. Moreover, either morphine- or oxycodone-induced increase in guanosine-5'-o-(3-thio) triphosphate ([(35)S]GTPgammaS) binding in the spinal cord, periaqueductal gray matter and thalamus in sciatic nerve-ligated mice was similar to that in sham-operated mice. Antinociception induced by s.c., intrathecal, or intracerebroventricular injection of the morphine metabolite morphine-6-glucuronide (M-6-G) was significantly decreased by sciatic nerve ligation. Furthermore, the increase in the G-protein activation induced by M-6-G was eliminated in sciatic nerve ligation. In addition, either morphine- or oxycodone-induced rewarding effect was dramatically suppressed under a neuropathic pain-like state. The increased [(35)S]GTPgammaS binding by morphine or oxycodone was significantly lower in the lower midbrain of mice with sciatic nerve ligation compared with that in control mice. These findings provide further evidence that oxycodone shows a profound antinociceptive effect under a neuropathic pain-like state with less of a rewarding effect. Furthermore, the reduction in G-protein activation induced by M-6-G may, at least in part, contribute to the suppression of the antinociceptive effect produced by morphine under a neuropathic pain-like state.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17593930     DOI: 10.1038/sj.npp.1301471

Source DB:  PubMed          Journal:  Neuropsychopharmacology        ISSN: 0893-133X            Impact factor:   7.853


  26 in total

1.  Study on the activation of the opioid receptors by a set of morphine derivatives in a well-defined assay system.

Authors:  Yan Zhang; Zhiwei Wang; D Phillip Cox; Olivier Civelli
Journal:  Neurochem Res       Date:  2011-10-16       Impact factor: 3.996

2.  mu-Opioid receptor-independent fashion of the suppression of sodium currents by mu-opioid analgesics in thalamic neurons.

Authors:  Keisuke Hashimoto; Taku Amano; Akiko Kasakura; George R Uhl; Ichiro Sora; Norio Sakai; Naoko Kuzumaki; Tsutomu Suzuki; Minoru Narita
Journal:  Neurosci Lett       Date:  2009-01-30       Impact factor: 3.046

3.  G protein-gated inwardly rectifying potassium (KIR3) channels play a primary role in the antinociceptive effect of oxycodone, but not morphine, at supraspinal sites.

Authors:  Atsushi Nakamura; Masahide Fujita; Hiroko Ono; Yoshie Hongo; Tomoe Kanbara; Koichi Ogawa; Yasuhide Morioka; Atsushi Nishiyori; Masahiro Shibasaki; Tomohisa Mori; Tsutomu Suzuki; Gaku Sakaguchi; Akira Kato; Minoru Hasegawa
Journal:  Br J Pharmacol       Date:  2014-01       Impact factor: 8.739

Review 4.  Oxycodone combinations for pain relief.

Authors:  R B Raffa; J V Pergolizzi; D J Segarnick; R J Tallarida
Journal:  Drugs Today (Barc)       Date:  2010-06       Impact factor: 2.245

5.  Sex Differences in the Rat Hippocampal Opioid System After Oxycodone Conditioned Place Preference.

Authors:  James D Ryan; Yan Zhou; Natalina H Contoreggi; Farah K Bshesh; Jason D Gray; Joshua F Kogan; Konrad T Ben; Bruce S McEwen; Mary Jeanne Kreek; Teresa A Milner
Journal:  Neuroscience       Date:  2018-10-11       Impact factor: 3.590

6.  Oxycodone-induced conditioned place preference and sensitization of locomotor activity in adolescent and adult mice.

Authors:  Keiichi Niikura; Ann Ho; Mary Jeanne Kreek; Yong Zhang
Journal:  Pharmacol Biochem Behav       Date:  2013-07-01       Impact factor: 3.533

7.  GpTx-1 and [Ala5 , Phe6 , Leu26 , Arg28 ]GpTx-1, two peptide NaV 1.7 inhibitors: analgesic and tolerance properties at the spinal level.

Authors:  Chao Chen; Biao Xu; Xuerui Shi; Mengna Zhang; Qinqin Zhang; Ting Zhang; Weidong Zhao; Run Zhang; Zilong Wang; Ning Li; Quan Fang
Journal:  Br J Pharmacol       Date:  2018-09-09       Impact factor: 8.739

8.  Behavioral and neurochemical changes induced by oxycodone differ between adolescent and adult mice.

Authors:  Yong Zhang; Roberto Picetti; Eduardo R Butelman; Stefan D Schlussman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropsychopharmacology       Date:  2008-09-10       Impact factor: 7.853

9.  Differential activation of the μ-opioid receptor by oxycodone and morphine in pain-related brain regions in a bone cancer pain model.

Authors:  Atsushi Nakamura; Minoru Hasegawa; Kazuhisa Minami; Tomoe Kanbara; Takako Tomii; Atsushi Nishiyori; Minoru Narita; Tsutomu Suzuki; Akira Kato
Journal:  Br J Pharmacol       Date:  2013-01       Impact factor: 8.739

10.  Orally active opioid μ/δ dual agonist MGM-16, a derivative of the indole alkaloid mitragynine, exhibits potent antiallodynic effect on neuropathic pain in mice.

Authors:  Kenjiro Matsumoto; Minoru Narita; Naotaka Muramatsu; Terumi Nakayama; Kaori Misawa; Mariko Kitajima; Kimihito Tashima; Lakshmi A Devi; Tsutomu Suzuki; Hiromitsu Takayama; Syunji Horie
Journal:  J Pharmacol Exp Ther       Date:  2013-12-17       Impact factor: 4.030

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.